2019
DOI: 10.1038/s41429-019-0146-3
|View full text |Cite
|
Sign up to set email alerts
|

Modification of drug-binding proteins associated with the efflux pump in MDR-MTB in course of evolution: an unraveled clue based on in silico approach

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
3
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 6 publications
(3 citation statements)
references
References 18 publications
0
3
0
Order By: Relevance
“…In silico analysis for research regarding antimicrobial resistance will open a new avenue for scientists and the pharmaceutical industry as well as policymakers [88]. Molecular docking and homology modeling of the available drugs can be easily investigated [69,89]. In silico study will also help in understanding the drug resistant mechanism, prediction of traits responsible for AMR, protein-protein interaction, changes in structural conformation and analysis of mutational hotspot region [90].…”
Section: In Silico Analysismentioning
confidence: 99%
“…In silico analysis for research regarding antimicrobial resistance will open a new avenue for scientists and the pharmaceutical industry as well as policymakers [88]. Molecular docking and homology modeling of the available drugs can be easily investigated [69,89]. In silico study will also help in understanding the drug resistant mechanism, prediction of traits responsible for AMR, protein-protein interaction, changes in structural conformation and analysis of mutational hotspot region [90].…”
Section: In Silico Analysismentioning
confidence: 99%
“…Additionally, a recent study advises that Rv1634 protein is one of the 10 proteins crucial in the survival and in vivo growth of Mtb 19 . Furthermore, an in silico study state that in due course of time, Mtb MDR strains had evolved drug resistance by altering two of its transporter protein pumps, Rv1634 protein and Rv1258c protein, to extrude active drug compounds from their cellular environment 20 . A common characteristic of MDR proteins is the ability to transport various substrates, so there are fair chances that it may play as a potential target for new drugs in the future.…”
Section: Introductionmentioning
confidence: 99%
“…19 Furthermore, an in silico study state that in due course of time, Mtb MDR strains had evolved drug resistance by altering two of its transporter protein pumps, Rv1634 protein and Rv1258c protein, to extrude active drug compounds from their cellular environment. 20 A common characteristic of MDR proteins is the ability to transport various substrates, so there are fair chances that it may play as a potential target for new drugs in the future. Hence, the current study may enhance the understanding of mechanistic basis of drug binding, substrate specificity, and the transport of the MFS efflux pumps at molecular levels in general and specifically for multidrug-resistant Mtb strains.…”
mentioning
confidence: 99%